Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?
暂无分享,去创建一个
F. Fedele | M. Mancone | G. Biondi‐Zoccai | F. Infusino | F. Pugliese | E. Cavarretta | G. Frati | S. Cimino | M. Lombardi
[1] Michael Roth,et al. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.
[2] D. Gurwitz. Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics , 2020, Drug development research.
[3] Shengqing Wan,et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations , 2020, Cell Discovery.
[4] Andrea Marzi,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[5] G. Su,et al. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[6] G. Cai. Tobacco-Use Disparity in Gene Expression of ACE2, the Receptor of 2019-nCov , 2020 .
[7] I. Kickbusch,et al. Response to the emerging novel coronavirus outbreak , 2020, BMJ.
[8] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[9] L. Sakr,et al. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study , 2018, British Medical Journal.
[10] S. Bangalore,et al. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? , 2018, Journal of the American College of Cardiology.
[11] X. Li,et al. The vasoprotective axes of the renin‐angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases , 2017, Pharmacological research.
[12] O. Jahn,et al. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2013, Journal of Virology.
[13] S. Harrap,et al. The ACE2 gene: its potential as a functional candidate for cardiovascular disease. , 2013, Clinical science.
[14] K. Pyrć,et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. , 2012, The Journal of general virology.
[15] C. Disteche,et al. Genes that escape from X inactivation , 2011, Human Genetics.
[16] D. Tregouet,et al. A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project , 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[17] J. Penninger,et al. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[18] D. Gu,et al. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. , 2006, Clinical science.
[19] S. Perlman,et al. ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia , 2005, Journal of Virology.
[20] F. Frézard,et al. Angiotensin-(1-7): blood, heart, and blood vessels. , 2005, Current medicinal chemistry. Cardiovascular and hematological agents.
[21] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.
[22] Arthur S Slutsky,et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure , 2005, Nature.
[23] D. Diz,et al. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2 , 2005, Circulation.
[24] Chengsheng Zhang,et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2 , 2005, The EMBO journal.
[25] D. Moskowitz,et al. The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. , 2004, Current topics in medicinal chemistry.
[26] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[27] Nigel M Hooper,et al. ACE2: from vasopeptidase to SARS virus receptor , 2004, Trends in Pharmacological Sciences.
[28] R. Ardaillou. Angiotensin II receptors. , 1999, Journal of the American Society of Nephrology : JASN.